Cross-Asset Strategy: With equities trading near last summer’s highs and at above-average multiples, despite weakening earnings and the recent sharp move higher in interest rates, we maintain that markets are overpricing recent good news on inflation and are complacent of risks. Equity markets appeared to read this month’s central bank meetings as dovish, while dismissing the weak Q4 earnings and…
The J.P. Morgan View – Global Asset Allocation
A financial market resource for the every-day investor and trader.
-
Fitbit App Download Results Misleading, But Bump To Share Price Warranted
Seth Golden, , Research Reports, 0
If you want a misleading headline to take a stock higher, the recent power rankings in the Apple (AAPL)...
-
Merrill Lynch: Fighting Inflation
Seth Golden, , Research Reports, 0
Macro Strategy—Inflation Dimming Economic Outlook: On multiple levels, including strong labor demand, decades-low household leverage, lack of excesses on...
-
-
Stocks Go On Sales Into Quarter End: Mid-Year Outlook
Seth Golden, , Research Reports, 0
Welcome back Finom Group traders and investors. Although last weekend was our monthly off-reporting week, the market did not...
-
Weekly State of the Market: Bond Market Volatility Persists
Seth Golden, , Research Reports, 0
Welcome to this week’s State of the Markets. Please click the following link to review this week’s SOTM. In this week’s...
-
Fitbit’ Q1 2017 Results Highlight Inventory And Average Selling Price Reductions
Seth Golden, , Research Reports, 0
Fitbit (FIT) reported rather dismal Q1 2017 metrics last week, but even so shares of FIT rose sharply. Why...
-
Analysis and Updates From Wall Street
Seth Golden, , Research Reports, 0
Capital Economics We think the 10-year Treasury yield will end the year well below its current level. The sell-off in...
-
J.P. Morgan Guide To Markets
Seth Golden, , Research Reports, 0
1. The economy is holding up better than expected, but recession risk remains. In the third quarter, easing inflation...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00